Linked Life Data

10938942

Source:http://linkedlifedata.com/resource/pubmed/id/10938942

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2000-12-12
pubmed:abstractText
Several high-quality protocols exist that describe the methodological and technical aspects of the flow cytometric analyses of stem and progenitor cells. In addition, recent advances in automation and quantitative analyses show promising results. For further improvement of the test quality and more objective control, internal as well as external quality control is mandatory. In addition, cost aspects move into the focus of interest and have to be considered. Alternative methods such as volumetric capillary cytometry or haematological analyzers are of limited use for stem and progenitor cell analyses. Currently, flow cytometry represents the gold standard for monitoring the onset of apheresis and to evaluate the quality of stem and progenitor cell grafts. In the near future, only in vitro diagnostics that are CE-labelled or FDA-approved should be used for these analyses.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:issn
0042-9007
pubmed:author
pubmed:issnType
Print
pubmed:volume
78 Suppl 2
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Flow cytometry: the standard for monitoring the onset of apheresis and for the evaluation of stem and progenitor cell graft quality.
pubmed:affiliation
Dept. of Transfusion Medicine/Transplantation Immunology, University Hospital Eppendorf, Hamburg, Germany. gutensohn@uke.uni-hamburg.de
pubmed:publicationType
Journal Article, Review